"Fundado em 1948, o Banco de Sangue de São Paulo é uma empresa pioneira na prestação de serviços de Hemoterapia e Imunohematologia. Nesses mais de 60 anos de atividade, tem investido constantemente na implantação de novas tecnologias. Oferece, desta forma, atendimento adequado aos hospitais parceiros, além de segurança e qualidade a todos os pacientes que, por meio deles, fazem uso dos serviços do Banco de Sangue. Graças ao empenho de nossos profissionais, que primam pela excelência na qualidade da prestação de serviços, o Banco de Sangue de São Paulo tornou-se uma das principais referências em medicina transfusional privada do país."

During the past decade, GSH Banco de Sangue de São Paulo conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "GSH Banco de Sangue de São Paulo" are "Non-Transfusion-dependent Alpha-Thalassemia" (1 trials), "Non-Transfusion-dependent Beta-Thalassemia" (1 trials), "Transfusion-dependent Alpha-Thalassemia" (1 trials) and "Transfusion-dependent Beta-Thalassemia" (1 trials). Many other conditions were trialed in "GSH Banco de Sangue de São Paulo" in a lesser frequency.

Most popular intervention types in "GSH Banco de Sangue de São Paulo" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Mitapivat" (2 trials) and "Placebo Matching Mitapivat" (2 trials). Other intervention names were less common.

The vast majority of trials in "GSH Banco de Sangue de São Paulo" are 2 trials for "All" genders.

Currently, there are NaN active trials in "GSH Banco de Sangue de São Paulo". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in GSH Banco de Sangue de São Paulo, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in GSH Banco de Sangue de São Paulo, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".